The 5:2 diet for six months was feasible and efficient to reduce markers of insulin secretion and resistance and therefore holds promise as management of overweight/obesity in subjects with and without T2D. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.